Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone versus morphine for neonatal abstinence syndrome
IRCT20260329069018N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of methadone and morphine in neonatal abstinence syndrome (NAS) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Symptoms of deprivation syndrome and Length of hospitalization of newborns. Started Jun 2026; status: completed.
02
Drugs
methadonemorphine
03
Conditions
neonatal abstinence syndrome (NAS)
Beyond the preview
Go deeper on IRCT20260329069018N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260329069018N1.